Short answer
Rocket Lab Corp (RKLB) filed an 8-K current report with the SEC on August 13, 2026 reporting Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), Item EX-99.1 (Exhibit EX-99.1), Item EX-99.2 (Exhibit EX-99.2). August 13, 2026 press release announced an Equity Distribution Agreement, signaling potential equity issuance and shareholder dilution risk.
Rocket Lab Corp 8-K event analysis
AI summary of each reported item and its exhibits
Item 7.01 · Regulation FD Disclosure
- August 13, 2026 press release announced an Equity Distribution Agreement, signaling potential equity issuance and shareholder dilution risk
- Separate release reported progress toward Rocket Lab’s proposed acquisition of Iridium Communications, a potentially transformative strategic transaction
- Investors should review Exhibits 99.1 and 99.2 for financing terms, transaction milestones, and expected shareholder impact
Item 8.01 · Other Events
- ATM equity program authorizes up to $1.944B in common-stock sales, creating substantial funding capacity but potential shareholder dilution
- Sales-agent commissions up to 2.00%, reducing net proceeds and increasing capital-raising costs
- Forward contracts defer proceeds until settlement, with cash, share-delivery, and counterparty hedge risks
- Collared forwards establish floor and cap pricing, limiting downside proceeds and upside participation
- Stock-borrowing constraints could reduce forward transaction size, potentially to zero shares
Item EX-99.1 · Exhibit EX-99.1
- Replacement ATM program authorizes up to $1,944,369,826, carrying forward the prior agreement’s unsold capacity without increasing total shares offered
- Proceeds intended for cash payments tied to the proposed Iridium acquisition and reductions to the senior secured debt bridge facility
- Equity issuance is not contingent on completing Iridium, preserving funding flexibility but creating potential shareholder dilution
- Excess proceeds could fund future acquisitions, growth initiatives, and general corporate or working capital needs
Item EX-99.2 · Exhibit EX-99.2
- HSR antitrust waiting period expired August 12, advancing the proposed Iridium acquisition without early U.S. antitrust intervention
- Form S-4 filed August 13 to register Rocket Lab shares for Iridium shareholders, moving the transaction toward shareholder approval
- FCC applications filed August 10 to transfer Iridium licenses and authorizations, with regulatory approval still outstanding
- $3.6B, 364-day bridge facility targeted for replacement with permanent debt and equity financing
- Iridium’s $1.775B term loan may remain outstanding at lower rates, subject to lender consent; new ATM equity program supports bridge refinancing
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Rocket Lab Corp 8-K filings
Get the next RKLB 8-K as it lands
Follow RKLB for push alerts, or ask the research agent what this filing means.